Journal
BIOMOLECULES & THERAPEUTICS
Volume 19, Issue 4, Pages 451-459Publisher
KOREAN SOC APPLIED PHARMACOLOGY
DOI: 10.4062/biomolther.2011.19.4.451
Keywords
Peroxiredoxin I; Peroxiredoxin II; ROS; MEF
Funding
- National Research Foundation of Korea (NRF)
- Ministry of Education, Science and Technology [KRF-2008-313-E00018]
Ask authors/readers for more resources
Peroxiredoxins (Prxs) have a critical role in protecting cells against oxidative damage generated by reactive oxygen species (ROS). Prxl and Prxl I are more than 90% homologous in their amino acid sequences, and both proteins reduce H(2)O(2). In this study, an over-expression plasmid carrying Prxl was transfected into PrxII(-/-) mouse embryonic fibroblasts (MEFs) to investigate potential compensatory relationships between Prxl and PrxII. ROS levels induced by oxidative stress were increased in PrxII(-/-) MEFs as compared to wild-type MEFs. Moreover, exposure of PrxII(-/-) MEFs to H(2)O(2) caused a reduction in cell viability of about 10%, and the proportion of cell death was increased compared to mock-treated PrxII(-/-) MEFs. However, transient over-expression of Prxl in PrxII(-/-) MEFs conferred increased resistance against the oxidative damage, as evidenced by increased cell viability and reduced intracellular ROS levels under H(2)O(2) stress conditions. The findings suggest that over-expressed Prxl can partly compensate for the loss of Prxl I function in PrxII-deficient MEFs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available